BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shaberman B. A Retinal Research Nonprofit Paves the Way for Commercializing Gene Therapies. Hum Gene Ther. 2017;28:1118-1121. [PMID: 29227172 DOI: 10.1089/hum.2017.29058.bsh] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Yerxa B. Progress in Inherited Retinal Disease Drug Discovery and Development: A Foundation's Perspective. Pharm Res 2018;35:239. [PMID: 30338398 DOI: 10.1007/s11095-018-2514-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jimenez J, Sakthivel M, Nischal KK, Fedorchak MV. Drug delivery systems and novel formulations to improve treatment of rare corneal disease. Drug Discov Today 2019;24:1564-74. [PMID: 30872110 DOI: 10.1016/j.drudis.2019.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Benger M, Kinali M, Mazarakis ND. Autism spectrum disorder: prospects for treatment using gene therapy. Mol Autism 2018;9:39. [PMID: 29951185 DOI: 10.1186/s13229-018-0222-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]